Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,730 | 19,294 | 21,826 | 40,556 | 41,728 |
| Receivables | 2,011 | 1,791 | 1,912 | 0 | 0 |
| Inventories | 4,251 | 3,710 | 3,290 | 270 | 205 |
| Other current assets | 0 | 0 | 0 | 8 | 8 |
| TOTAL | $26,099 | $24,947 | $27,312 | $40,861 | $41,989 |
| Non-Current Assets | |||||
| PPE Net | 367 | 368 | 394 | 4 | 2 |
| Intangibles | 1,234 | 948 | 777 | 0 | 0 |
| Other Non-Current Assets | 711 | 728 | 760 | 0 | 0 |
| TOTAL | $2,311 | $2,044 | $1,932 | $4 | $2 |
| Total Assets | $28,410 | $26,991 | $29,244 | $40,864 | $41,991 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,308 | 6,368 | 6,435 | 480 | 105 |
| TOTAL | $4,660 | $6,906 | $6,931 | $480 | $105 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 597 | 613 | 642 | 0 | 0 |
| TOTAL | $640 | $656 | $685 | $N/A | $N/A |
| Total Liabilities | $5,300 | $7,562 | $7,616 | $480 | $105 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13 | 11 | 11 | 11 | 9 |
| Common Shares | 26 | 22 | 23 | 19 | 19 |
| Retained earnings | -62,004 | -61,102 | -59,400 | -35,887 | -34,430 |
| Other shareholders' equity | 665 | 173 | 162 | -80 | -35 |
| TOTAL | $23,110 | $19,430 | $21,628 | $40,384 | $41,886 |
| Total Liabilities And Equity | $28,410 | $26,991 | $29,244 | $40,864 | $41,991 |